Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ZnAl BrO3 LDHs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107089919B reveals a green ZnAl-LDHs catalytic route for monobromoaniline. Achieve high selectivity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107628945B reveals a green synthesis route for beta-bromoformates using ZnAl-LDHs catalyst, offering cost reduction in API manufacturing and enhanced supply chain reliability.